نتائج البحث - "High dose melphalan"

1

Publisher Correction

المساهمون: Hematology, Basic (bio-) Medical Sciences

مصطلحات موضوعية: Oncology, high-dose melphalan, Cancer Research, medicine.medical_specialty, Bortezomib, business.industry, hematology, lenalidomide, Medizin, High dose melphalan, myeloma, Internal medicine, oncology, medicine, business, Bortezomib-based induction, Lenalidomide, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683fb2bdb48b3c1b3cb39211af9e1813
https://hdl.handle.net/20.500.14017/d95b8682-3f21-444c-a851-40ea53cb6c03

2

Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis

المؤلفون: Luke Zheng, Vaishali Sanchorawala, Dina Brauneis, J. Mark Sloan, Shayna Sarosiek, Karen Quillen

المصدر: Blood Cancer Journal, Vol 10, Iss 8, Pp 1-6 (2020)
Blood Cancer Journal

مصطلحات موضوعية: Adult, Male, Immunofixation, Melphalan, medicine.medical_specialty, Myeloma, Gastroenterology, lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, AL amyloidosis, Humans, Medicine, Immunoglobulin Light-chain Amyloidosis, Antineoplastic Agents, Alkylating, Aged, biology, business.industry, High dose melphalan, Hematology, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Analysis, Electrophoreses, Hematologic Response, Transplantation, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, biology.protein, Female, Immunoglobulin Light Chains, Stem cell, business, Haematological diseases, Stem Cell Transplantation, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a72fc1e3cc1b2934401bc222268a9188
http://link.springer.com/article/10.1038/s41408-020-00354-7

Find this article in full text from ProQuest

3

Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: Leukemia

مصطلحات موضوعية: Adult, Male, Melphalan, Cancer Research, medicine.medical_specialty, Multiple Myeloma/drug therapy, Medizin, Myeloma, Induction Chemotherapy/mortality, Article, Bortezomib, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide/administration & dosage, Humans, Medicine, Prospective Studies, Adverse effect, Lenalidomide, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Correction, High dose melphalan, Consolidation Chemotherapy/mortality, Induction Chemotherapy, Hematology, Middle Aged, Prognosis, medicine.disease, Stem-cell research, Consolidation Chemotherapy, Survival Rate, Transplantation, Oncology, Toxicity, Randomized controlled trials, Bortezomib/administration & dosage, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Multiple Myeloma, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abdfae6314551f474fd5c284e7f37463
https://doi.org/10.1038/s41375-020-0976-9

Find this article in full text from ProQuest

4

Relationship between Adverse Events and AUC in Japanese Patients with Multiple Myeloma Receiving High-dose Melphalan

المؤلفون: Hideki Kakimoto, Osamu Imakyure, Hidetoshi Kamimura, Akane Nagasato, Koichi Matsuo, Motoyasu Miyazaki, Yasushi Takamatsu, Masanobu Uchiyama

المصدر: Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 46:396-402

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine, High dose melphalan, business, Adverse effect, medicine.disease, Multiple myeloma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2c013087c0e749ba1e94429a45152a0b
https://doi.org/10.5649/jjphcs.46.396

5

Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients

المؤلفون: Lucia Prezioso, Nicola Giuliani, Fabrizio Accardi, Laura Notarfranchi, Benedetta Dalla Palma

المصدر: Leukemia & Lymphoma. 61:1238-1241

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e40803bc6960cf6482bf3da175ba7fa
https://doi.org/10.1080/10428194.2019.1706735

PDF full text from Publisher

6

Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis

المؤلفون: Noon Elhassan, Vaishali Sanchorawala, J. Mark Sloan, Janice Weinberg, Dina Brauneis, Vanessa Fiorini Furtado

المصدر: Bone marrow transplantation. 57(2)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144ea9cab3a29682e8908859595cbf28
https://pubmed.ncbi.nlm.nih.gov/34845368

Find this article in full text from ProQuest

7

Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis

المؤلفون: Frederico Rafael Moreira, A. Mendrone-Jr, M. C. B. Bittencourt, Vanderson Rocha, Livia Caroline Barbosa Mariano, J. Schmidt-Filho

المصدر: Bone Marrow Transplantation. 54:138-141

مصطلحات موضوعية: Oncology, Transplantation, medicine.medical_specialty, business.industry, High dose melphalan, Hematology, medicine.disease, Peripheral Blood Stem Cells, Cryopreservation, 03 medical and health sciences, 0302 clinical medicine, Text mining, 030220 oncology & carcinogenesis, Internal medicine, medicine, Autologous transplantation, business, Multiple myeloma, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4adcdc162a772bc15229a51b1e758deb
https://doi.org/10.1038/s41409-018-0250-1

Find this article in full text from ProQuest

8

Primary refractory multiple myeloma - what role for high dose melphalan?

المؤلفون: Sergio Giralt

المصدر: Leukemialymphoma. 61(12)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92298b31f05e65fedd74d7f9e64c857a
https://pubmed.ncbi.nlm.nih.gov/32623944

PDF full text from Publisher

9

Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)—study protocol for a multicenter randomized double-blind placebo-controlled trial

المؤلفون: Martijn Bakker, Walter J.F.M. van der Velden, Nicole M. A. Blijlevens, Bart J. Biemond, Anton F.J. de Haan, Lenneke F.J. van Groningen, Charlotte E. M. de Mooij

المساهمون: CCA - Cancer Treatment and Quality of Life, Clinical Haematology, AII - Infectious diseases

المصدر: Trials
Trials, 21(1):948. BioMed Central
TRIALS, 21(1):948. BMC
Trials, 21
Trials, 21, 1

مصطلحات موضوعية: medicine.medical_treatment, Placebo-controlled study, Medicine (miscellaneous), Pilot Projects, Hematopoietic stem cell transplantation, ORAL MUCOSITIS, THERAPY, law.invention, Study Protocol, INTERLEUKIN-1 RECEPTOR ANTAGONIST, 0302 clinical medicine, Autologous stem-cell transplantation, Randomized controlled trial, Multiple myeloma, law, Protocol, Multicenter Studies as Topic, Pharmacology (medical), Randomized Controlled Trials as Topic, Microbiota, Anakinra, HIGH-DOSE MELPHALAN, 030220 oncology & carcinogenesis, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, Mucositis, medicine.medical_specialty, Neutropenia, Febrile neutropenia, MUCOSAL BARRIER INJURY, Transplantation, Autologous, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Double-Blind Method, MULTIPLE-MYELOMA, Internal medicine, INTESTINAL MUCOSITIS, medicine, Humans, PALIFERMIN, business.industry, Other Research Radboud Institute for Health Sciences [Radboudumc 0], medicine.disease, Interleukin 1 Receptor Antagonist Protein, IL-1-BETA, INFLAMMASOME, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Quality of Life, business, Interleukin-1, 030215 immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c319c042f277e3b3265c505f30446c
https://doi.org/10.1186/s13063-020-04847-5

Find this article in full text from ProQuest

10

The Effect of Cryotherapy on the Prevention of Oral Mucositis and on the Oral pH Value in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

المؤلفون: Fusun Gediz, Güray Saydam, Dilek Sari, Seckin Cagirgan, Ayse Gungor, Fahri Şahin, Evin Timur, Ebru Baysal, Mahmut Töbü, Filiz Vural, Nur Soyer, Ceylan Acarlar

المصدر: Seminars in oncology nursing. 37(3)

مصطلحات موضوعية: Melphalan, medicine.medical_specialty, medicine.medical_treatment, Cryotherapy, Care, Transplantation, Autologous, Severity, Oral mucositis, 03 medical and health sciences, Nursing care, 0302 clinical medicine, Autologous stem-cell transplantation, Internal medicine, medicine, Mucositis, Chemotherapy, Humans, 030212 general & internal medicine, Multiple myeloma, Hematopoietic stem cell transplantation (HCST), Stomatitis, Oncology (nursing), business.industry, Hematopoietic Stem Cell Transplantation, Hydrogen-Ion Concentration, High-Dose Melphalan, medicine.disease, Clinical trial, Oral pH value, 030220 oncology & carcinogenesis, Randomized Controlled-Trial, Therapy, business, Multiple Myeloma, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1b7fc69cea578fccee0b62194e0f7d
https://pubmed.ncbi.nlm.nih.gov/34001407

View record from ScienceDirect

Full Text via ClinicalKey

تنقيح النتائج